Medical Licensing (MD/DO) · Independent exam preparation
ABPN Epilepsy Subspecialty Certification: Clinical Reasoning Guide Study Guide
Practise seizure classification, EEG interpretation, medication selection, emergency treatment, and referral decisions for ABPN epilepsy subspecialty certification.
By CertMedbry · Updated 17 October 2026
Build decisions from seizure history, electroclinical findings, treatment response, and patient priorities. This guide develops 60 selected concepts for the ABPN Subspecialty Certification Examination in Epilepsy, with particular attention to EEG interpretation and treatment decisions. The [official December 2025 content outline](https://abpn.org/wp-content/uploads/Epilepsy-Certification-Content-Specifications.pdf) defines the full preparation scope, including disorders and procedures beyond this selective guide.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which certification pathway does this guide address?
The initial Subspecialty Certification Examination in Epilepsy administered by ABPN. The October 2026 administration offers examination dates October 19–23. Applicants must meet ABPN requirements for prior general neurology or child neurology certification and qualifying epilepsy fellowship training. The historical practice pathway operated during 2013–2018; it should not be treated as the current admission pathway. Adult and pediatric epilepsy content belong to this same subspecialty examination.
How many questions are administered, and how many are scored?
The examination administers 220 questions in four sections of 55. ABPN states that questions included solely for research or pretesting do not contribute to the score. The format document does not specify how many questions are scored or how many are pretest questions.
Instructions for the Subspecialty Certification Examination in Epilepsy
How much time is available, including breaks?
Total testing time is 240 minutes: five minutes for the nondisclosure agreement and instructions, 230 minutes for questions, and five minutes for the concluding survey. Optional breaks are offered between sections, but examination time continues during them. A proctor must sign examinees back in after breaks.
Instructions for the Subspecialty Certification Examination in Epilepsy
What delivery method and question styles are verified?
The examination is computer delivered and consists entirely of stand-alone, one-best-answer multiple-choice questions. Questions may be skipped or flagged for review. The instructions describe four sections and do not describe adaptive delivery. These 20 educational questions are independent four-option drills; they do not reproduce the operational interface.
Instructions for the Subspecialty Certification Examination in Epilepsy
Which blueprint version and terminology apply?
The currently linked content specifications are dated December 2025; no separate effective date is stated. The format instructions were updated July 2, 2026 and direct candidates to current ILAE definitions and classifications. The issuer webpage's discussion of the 2020 transition to 2017 terminology is historical. This guide uses the 2025 seizure-classification framework, including consciousness terminology.
ABPN Epilepsy Certification Content Specifications — December 2025 · Instructions for the Subspecialty Certification Examination in Epilepsy · ILAE — Updated Classification of Epileptic Seizures (2025)
How do the two blueprint dimensions work?
Each examination item maps to both a disorder/topic and a competency; the dimensions overlap and their percentages must not be added. Competency weights are Neuroscience and mechanism of disease 4–6%; Clinical aspects of neurologic disease 17–23%; Diagnostic procedures 31–39%; Treatment/Management 31–39%; Interpersonal and communication skills 1–3%; Professionalism 1–2%; Practice-based learning and improvement 1–2%; and Systems-based practice 1–2%. The 60 concepts allocate 3, 12, 20, 21, 1, 1, 1, and 1 concepts respectively. Short question and card sets necessarily round these ranges.
ABPN Epilepsy Certification Content Specifications — December 2025
Which disorder groups define the broader examination scope?
The disorder dimension assigns Epilepsy and episodic disorders 74–86%; Genetic and developmental disorders 3–5%; Vascular neurology 1–2%; Neuroinfectious diseases 1–2%; Metabolic diseases, nutritional deficiency states, and disorders due to toxins, drugs, and physical agents 1–2%; Neuro-oncologic disorders 1–2%; Behavioral neurology and neurocognitive disorders 1–2%; Psychiatric disorders 1–2%; Questions not associated with a specific neurologic disorder 6–10%; and Neuroimmunologic and paraneoplastic CNS disorders 1–3%. Use the full official outline to extend preparation beyond these selected concepts.
ABPN Epilepsy Certification Content Specifications — December 2025
What scoring information and practice resources are available?
ABPN reports a total percent-correct score and subtest scores. Passing requires acceptable total performance; standards are not norm referenced, and no passing rate is predetermined. The instructions do not publish a numerical passing threshold. There is no penalty for guessing. ABPN links a demonstration examination for interface familiarization; it does not provide a score or post-completion answer review. These educational drills do not predict certification results.
Instructions for the Subspecialty Certification Examination in Epilepsy
This is physician subspecialty certification awarded by the American Board of Psychiatry and Neurology, Inc. It is distinct from medical licensure, general neurology certification, clinical neurophysiology certification, and continuing certification. The guide and drills are independently authored educational materials.
Outline used: ABPN Epilepsy Certification Content Specifications, dated December 2025 and currently linked for the October 19–23, 2026 initial certification examination; no separate effective date is stated. Format and scoring instructions updated July 2, 2026. The workbook label 'American Board of Psychiatry and Neurology - Subspecialty in Epilepsy' maps to the official Subspecialty Certification Examination in Epilepsy; the assigned canonical slug is preserved.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Neuroscience and mechanism of disease4-6%
1.Why can GLUT1 deficiency cause seizures despite normal blood glucose?
GLUT1, encoded by SLC2A1, transports glucose across the blood–brain barrier. Reduced transport can deprive the brain of fuel even when circulating glucose is normal. The resulting cerebral energy deficit can produce seizures, developmental impairment, and movement disorders. Normal peripheral glucose therefore does not exclude a cerebral glucose-transport disorder. Ketogenic dietary therapy addresses this mechanism by supplying ketone bodies as an alternative cerebral fuel.
Apply it
A child has early seizures, developmental slowing, and exercise-related dystonia despite normal blood glucose. Investigate cerebral glucose transport and, if GLUT1 deficiency is established, arrange specialist-supervised ketogenic therapy.
Common pitfall: Equating normal blood glucose with normal brain fuel availability overlooks the transport barrier; antiseizure medication alone does not correct that metabolic defect.
GeneReviews — Glucose Transporter Type 1 Deficiency Syndrome · epi4.12414.pdf
2.How can altered membrane excitation change excitatory synaptic transmission?
Membrane ion channels and neurotransmitter receptors represent distinct sites at which neuronal excitation can be modified. Lamotrigine illustrates this distinction: in vitro studies suggest inhibition of voltage-sensitive sodium channels, stabilization of neuronal membranes, and modulation of presynaptic release of excitatory amino acids, including glutamate and aspartate. Reduced excitatory transmitter release can therefore arise through an upstream membrane effect rather than direct blockade of the postsynaptic glutamate receptor. The prescribing information describes this as a proposed mechanism whose relevance to human anticonvulsant activity remains incompletely established.
Apply it
An experiment shows reduced glutamate release after lamotrigine exposure. Explain the proposed sodium-channel mechanism rather than inferring direct NMDA-receptor antagonism. The labeling reports that lamotrigine did not inhibit NMDA-induced depolarization in rat cortical slices.
Common pitfall: Do not equate every reduction in glutamatergic transmission with direct glutamate-receptor blockade. Distinguish membrane excitability, presynaptic transmitter release, and postsynaptic receptor activation when interpreting a mechanistic experiment.
ABPN Epilepsy Certification Content Specifications — December 2025 · DailyMed — Lamotrigine Prescribing Information
3.How can reduced sodium current promote network hyperexcitability?
The network effect depends on which neurons lose sodium current. If inhibitory interneurons cannot sustain action-potential firing, their inhibitory output falls and downstream neurons can become disinhibited. In the [original Scn1a mouse-model study](https://pubmed.ncbi.nlm.nih.gov/16921370/), loss of Nav1.1 function reduced sodium current in hippocampal GABAergic interneurons, with impaired firing; a comparable sodium-current reduction was not found in pyramidal neurons. These experimental findings support an interneuron-disinhibition mechanism relevant to understanding SCN1A-associated epilepsy. They are mouse-model observations, not direct measurements in human patients, and do not establish an identical cellular effect for every human SCN1A variant.
Apply it
A model shows reduced interneuron sodium current and firing while pyramidal-cell sodium current is preserved. Predict reduced inhibitory control and increased network seizure susceptibility rather than assuming that less sodium current must suppress the entire network.
Common pitfall: A channel's excitatory role within an individual inhibitory neuron differs from that neuron's inhibitory role in the network. Mechanistic mouse findings also cannot, by themselves, determine treatment for every human channel variant.
ABPN Epilepsy Certification Content Specifications — December 2025
Clinical aspects of neurologic disease17-23%
4.When can epilepsy be diagnosed after one unprovoked seizure?
The ILAE clinical definition allows epilepsy to be diagnosed after two unprovoked or reflex seizures more than 24 hours apart, after one such seizure when the estimated probability of further seizures is at least 60% over the next 10 years, or when an epilepsy syndrome is diagnosed. A single event therefore requires assessment of enduring recurrence risk and syndrome evidence. An acute provoking disturbance is a different context and does not automatically establish epilepsy.
Apply it
An adult has one unprovoked seizure and a documented clinical situation associated with a recurrence probability exceeding the ILAE threshold. Explain why the diagnosis can be established without waiting for a second seizure.
Common pitfall: Requiring two seizures in every patient misses the risk-based and syndrome-based routes; conversely, counting every acutely provoked seizure as epilepsy overstates an enduring predisposition.
ILAE Official Report — A Practical Clinical Definition of Epilepsy
5.When is epilepsy considered resolved?
The ILAE considers epilepsy resolved when an individual has passed the applicable age of an age-dependent epilepsy syndrome, or has remained seizure-free for the last 10 years and off antiseizure medicines for at least the last five years. Both time requirements apply to the latter route. Resolved is a defined clinical status rather than a promise that recurrence is impossible. Medication withdrawal decisions require their own individualized assessment and should not be inferred from this definition alone.
Apply it
A patient has been seizure-free for 12 years but stopped medication only three years ago. Explain that the general time-based definition of resolved epilepsy has not yet been met despite the long seizure-free interval.
Common pitfall: Using five seizure-free years alone, or ignoring time off medication, changes the definition and may create unwarranted certainty about future recurrence risk for the patient.
ILAE Official Report — A Practical Clinical Definition of Epilepsy
6.How is consciousness assessed when awareness and responsiveness disagree?
The 2025 ILAE framework assesses awareness through recall and responsiveness through appropriate verbal and motor responses compared with baseline. After considering confounders such as receptive aphasia, ictal paresis, and isolated epileptic amnesia, impairment of either component supports impaired consciousness. Preserved consciousness requires both awareness and responsiveness to be preserved. If consciousness cannot be determined, retain the parent classification, such as focal seizure, rather than assigning an unsupported consciousness subtype.
Apply it
During an established focal seizure, a patient later recalls the examiner's words accurately but could not respond appropriately to verbal or nonverbal tasks. After excluding language and motor explanations, classify impaired consciousness despite preserved recall.
Common pitfall: Preserved recall does not override demonstrated impaired responsiveness. Conversely, an isolated failed verbal command requires assessment for aphasia before inferring impaired consciousness.
7.When should a seizure remain unknown whether focal or generalized?
A bilateral tonic-clonic appearance does not by itself establish generalized origin because a focal seizure may spread bilaterally. The 2025 classification retains an unknown whether focal or generalized class when available evidence cannot support either origin. Review the earliest symptoms, witness observations, recordings, and EEG before refining classification. This approach preserves useful descriptive information while preventing an unsupported origin label from shaping syndrome diagnosis or medication selection prematurely in subsequent care.
Apply it
A partner awakens to bilateral convulsions but did not observe onset. The patient reports no reliable preceding symptoms, and the initial studies are nondiagnostic. Retain uncertainty about origin while continuing a targeted assessment.
Common pitfall: Calling every bilateral convulsion generalized erases focal-to-bilateral seizures; inventing focal onset from an unwitnessed beginning is equally unsupported by the available clinical evidence in this setting.
8.Which history most strongly suggests juvenile myoclonic epilepsy?
Juvenile myoclonic epilepsy is characterized by myoclonic seizures, typically beginning in adolescence and often occurring after awakening. Generalized tonic-clonic seizures are common, and absence seizures may also occur. Ask specifically about brief morning jerks that cause dropped objects because patients may not identify them as seizures. The combination of age, timing, seizure types, and generalized EEG abnormalities is more informative than a tonic-clonic seizure considered in isolation during syndrome assessment.
Apply it
A teenager presents after a morning convulsion following sleep loss. Targeted questioning reveals months of dropping a toothbrush during brief bilateral arm jerks after waking. Integrate these earlier events into the syndrome diagnosis.
Common pitfall: Treating morning myoclonus as ordinary clumsiness can hide the defining seizure type and encourage a classification based only on the most dramatic presenting convulsion.
ILAE EpilepsyDiagnosis.org — Juvenile Myoclonic Epilepsy: Overview
9.Why must absence presentations be screened for other seizure types?
Brief staring episodes do not establish childhood absence epilepsy without considering age, electroclinical findings, and the complete seizure inventory. Myoclonic or generalized tonic-clonic seizures can indicate a different generalized epilepsy context and change medication coverage requirements. The childhood absence trial evaluated a defined syndrome population, while ethosuximide labeling addresses absence seizures and cautions about mixed seizure types. Ask about morning jerks and convulsions before extrapolating a pure-absence treatment strategy to a broader presentation.
Apply it
A child referred for staring spells also describes repeated morning arm jerks and has experienced a generalized convulsion. Reassess the syndrome and required seizure coverage before choosing an absence-specific medication as sole treatment.
Common pitfall: Allowing the referral label of absence epilepsy to replace a full seizure history can produce a medication plan that leaves another clinically important seizure type untreated.
ILAE EpilepsyDiagnosis.org — Juvenile Myoclonic Epilepsy: Overview · DailyMed — Ethosuximide Oral Solution Prescribing Information
10.Which features favor vasovagal syncope over an epileptic convulsion?
Vasovagal syncope commonly follows a recognizable trigger such as prolonged standing and may be preceded by lightheadedness, visual dimming, nausea, sweating, or pallor. Brief stiffening or irregular jerks can accompany cerebral hypoperfusion, so movements do not prove epilepsy. Rapid restoration of orientation supports syncope, whereas prolonged post-event confusion raises a different concern. Reconstruct the trigger, prodrome, sequence, duration, and recovery rather than using a single dramatic witness description as the diagnosis.
Apply it
A student becomes pale while standing in a hot room, reports tunnel vision, collapses, and has several brief jerks. Orientation returns promptly when supine. The sequence supports syncope despite the witnessed movements.
Common pitfall: Using any witnessed jerking as proof of epilepsy ignores convulsive movements during hypoperfusion and can lead to unnecessary antiseizure treatment while the actual cause remains unaddressed.
11.Which blackout features raise concern for cardiac syncope?
Collapse during exercise, a history of palpitations, or a family history of sudden unexplained death should raise concern for a cardiac cause of transient loss of consciousness. Cardiac syncope can include stiffening or jerks and may be misclassified as epilepsy. These warning features justify targeted cardiac assessment even when a witness reports convulsive movements. The essential distinction is the mechanism of loss of consciousness, not merely whether movement occurred during the collapse.
Apply it
A young athlete collapses during running, with brief jerking and rapid recovery. A sibling died unexpectedly in early adulthood. Prioritize evaluation for a potentially dangerous cardiac mechanism rather than assuming a new epilepsy diagnosis.
Common pitfall: A previous seizure label or the presence of jerks should not override exertional collapse and familial sudden-death clues that require investigation for a cardiac cause.
12.When should infantile epileptic spasms remain a concern without hypsarrhythmia?
Epileptic spasms are brief events that may occur in clusters and can be subtle, making caregiver video and developmental history valuable. Hypsarrhythmia is an important associated EEG pattern, but its absence does not exclude infantile epileptic spasms syndrome. EEG abnormalities may depend on disease stage and behavioral state. A convincing clinical pattern warrants prompt electroclinical assessment rather than reassurance based solely on an awake recording that lacks the classic interictal pattern.
Apply it
An infant has repeated brief flexor movements in clusters after waking and recent developmental slowing. An initial awake EEG lacks hypsarrhythmia. Arrange prompt assessment including sleep and event capture instead of dismissing the episodes.
Common pitfall: Treating hypsarrhythmia as an obligatory finding on every recording can delay evaluation of clinically convincing spasms, especially when sleep or habitual events were not sampled.
ILAE EpilepsyDiagnosis.org — Infantile Epileptic Spasms Syndrome: EEG
13.Which seizure and EEG findings are mandatory for Lennox-Gastaut syndrome?
The ILAE criteria require tonic seizures plus at least one additional qualifying type: atypical absences, atonic seizures, myoclonic seizures, focal seizures with impaired consciousness, generalized tonic-clonic seizures, epileptic spasms, or nonconvulsive status epilepticus. Mandatory EEG findings are generalized slow spike-wave below 2.5 Hz and generalized paroxysmal fast activity in sleep, with fast activity at least 10 Hz. The full criteria also address onset before age 18, drug resistance, and intellectual impairment.
Apply it
A child with developmental impairment and drop attacks needs confirmation of tonic seizures and review of waking and sleep EEG. Atonic events and nonspecific slowing alone do not establish Lennox-Gastaut syndrome.
Common pitfall: Multiple seizure types and developmental impairment are insufficient without the required seizure and EEG profile. Historical EEG can establish slow spike-wave that has disappeared by adulthood.
LENNOX-GASTAUT SYNDROME (LGS) · ILAE EpilepsyDiagnosis.org — Lennox-Gastaut Syndrome: EEG
14.Why are faciobrachial dystonic seizures an important immune clue?
Very brief, frequent dystonic events involving the face and arm can precede the cognitive syndrome of LGI1 antibody-associated limbic encephalitis. Emerging memory impairment and hyponatremia strengthen this association. The original study identified a clinically recognizable sequence in which these seizures could appear before established limbic dysfunction. Recognizing that sequence should prompt evaluation for an immune-mediated disorder rather than interpreting frequent, short events as automatically behavioral or waiting for profound encephalopathy to develop.
Apply it
An older adult develops dozens of brief unilateral face-arm dystonic episodes each day. Family members then notice recent-memory difficulty, and testing shows hyponatremia. Investigate an LGI1-associated process rather than treating the movements as an isolated motor complaint.
Common pitfall: The events' brevity can encourage dismissal as a movement disorder, but their stereotyped distribution and evolving cognitive context provide a potentially time-sensitive etiologic clue.
Faciobrachial Dystonic Seizures Precede LGI1 Antibody Limbic Encephalitis
15.Which seizure feature most strongly informs SUDEP risk reduction?
Generalized tonic-clonic seizure occurrence and increasing frequency are major established risk factors for sudden unexpected death in epilepsy. Seizure freedom, especially freedom from tonic-clonic seizures, is associated with reduced risk. Counseling should connect this evidence to adherence and a practical seizure-control plan while acknowledging that population estimates do not determine an individual's outcome. The clinically useful response is to identify ongoing convulsive seizures and address modifiable contributors without implying that risk can be eliminated.
Apply it
A patient with recurrent tonic-clonic seizures frequently misses medication because of adverse effects. Discuss SUDEP in understandable terms and use the conversation to build a tolerable adherence and seizure-control plan with follow-up.
Common pitfall: Providing a population risk number without discussing convulsive seizure burden or actionable barriers leaves the patient informed about danger but unsupported in reducing a major risk factor.
AAN/AES Clinician Summary — SUDEP Incidence Rates and Risk Factors
Diagnostic procedures31-39%
16.What does a normal routine interictal EEG establish?
A normal routine EEG means that the sampled recording did not demonstrate an identified abnormality under its recording conditions. It does not exclude epilepsy because interictal epileptiform activity can be intermittent and may not appear during a brief study. Diagnostic interpretation must remain tied to the clinical history and sampling conditions. Conversely, an EEG report should not claim that a normal result proves the patient's events are nonepileptic or resolves a strong electroclinical suspicion.
Apply it
A patient reports recurrent stereotyped episodes with amnesia, but a short awake EEG is normal. Retain the clinical differential and select further recording based on the unresolved question rather than declaring epilepsy excluded.
Common pitfall: Turning a normal interictal sample into a rule-out test confuses absence of recorded evidence with evidence that the patient's recurrent clinical events cannot be epileptic.
17.How can sleep recording improve an epilepsy evaluation?
Sleep can activate epileptiform abnormalities and reveal patterns that are poorly represented during wakefulness. Recording standards therefore address sleep acquisition and appropriate activation strategies when the clinical question requires them. A repeat study should be designed to improve relevant sampling rather than simply reproduce an identical inadequate recording. Behavioral state, technical quality, and the syndrome under consideration determine whether a normal waking sample sufficiently addresses the question posed by the patient's history.
Apply it
An initial EEG captures only wakefulness in a child whose events occur around sleep. Plan a study that includes sleep and synchronized observation so the second assessment samples the state most relevant to the concern.
Common pitfall: Repeating the same limited awake protocol without addressing state dependence may add little information and can create false reassurance from multiple similarly incomplete samples over time.
18.When and how should hyperventilation be used during EEG?
Screen for contraindications before activation, including sickle cell disease or trait, Moyamoya disease, and a cerebrovascular event within the preceding three months. When appropriate, obtain adequate effort for at least three minutes, typically 15–30 deep breaths per minute, document effort, and record at least two minutes afterward. Observe behavior and test responsiveness during suspected seizures. Physiological generalized slowing during hyperventilation is different from generalized spike-wave accompanied by an electroclinical absence.
Apply it
For a child with brief staring spells and no contraindication, encourage adequate breathing and test counting or command-following during a generalized spike-wave burst. For a patient with a recent stroke, omit hyperventilation and document the reason.
Common pitfall: Inadequate effort limits interpretation. Lightheadedness or physiological slowing alone does not establish an absence seizure; the EEG pattern and behavioral change must be assessed together.
19.How are photic driving, photomyogenic responses, and photoparoxysmal responses distinguished?
Posterior photic driving is rhythmic occipital cerebral activity related to the flash frequency or its harmonics, without an epileptiform spike-wave morphology. A photomyogenic response consists of brief, flash-locked muscle potentials, usually prominent anteriorly, associated with eyelid or facial contraction and ending with stimulation; video and EMG help identify its muscular origin. A photoparoxysmal response contains epileptiform spikes, polyspikes, or spike-wave, potentially spreading beyond posterior regions or persisting after the train. Stop the current stimulus train immediately when generalized epileptiform discharges appear. Observe clinical signs and test responsiveness and subsequent recall to determine whether an electroclinical seizure accompanies the EEG response.
Apply it
Flashes produce generalized polyspike-wave. Stop that train immediately, observe the patient, and test responsiveness and recall. If no clinical change is demonstrated, report the photoparoxysmal response without claiming that a habitual clinical seizure was captured.
Common pitfall: Flash locking alone does not distinguish physiological driving, muscle responses, and epileptiform activity. Do not continue stimulation to obtain a longer generalized discharge, and do not mistake photomyogenic artifact for a seizure.
Routine-and-sleep-EEG-Minimum-recording-standards-of-the-internationa-federation-of-clinical-neurophysiology-and-the-international-league-against-epilepsy.pdf · ILAE EpilepsyDiagnosis.org — Juvenile Myoclonic Epilepsy: EEG
20.Why pair synchronized video with responsiveness testing?
Synchronized video establishes the temporal relationship between recorded electrical activity and visible behavior. Purposeful responsiveness testing adds information about clinical impairment that passive observation may miss. Together they help distinguish electroclinical seizures, isolated EEG abnormalities, and movement artifacts. Documentation should state what was tested and what the person did, because later recall alone may be incomplete. Neither an EEG tracing detached from behavior nor a video detached from the recording supplies the entire electroclinical assessment.
Apply it
A patient has brief pauses during monitoring. Staff give simple commands and a word to remember while recording synchronized video. Compare responses, subsequent recall, and EEG timing to characterize the event more precisely.
Common pitfall: Assuming that stillness proves impaired consciousness, or that any movement proves preserved consciousness, substitutes impression for a documented assessment of the patient's actual behavior during the event.
Routine-and-sleep-EEG-Minimum-recording-standards-of-the-internationa-federation-of-clinical-neurophysiology-and-the-international-league-against-epilepsy.pdf · updated-classification-of-epileptic-seizures-2025.pdf
21.How does an ECG channel help identify EEG artifact?
An ECG channel provides an independent reference for cardiac timing during EEG. Repetitive sharp transients that maintain a fixed relationship to the QRS complexes may reflect cardiac contamination rather than cerebral epileptiform discharges. Examine the scalp field, morphology, and timing together, because apparent sharpness alone is insufficient. Recording standards recommend an ECG channel as part of routine and sleep EEG, improving recognition of both artifact and potentially relevant rhythm information during a clinical event.
Apply it
Sharp repetitive deflections appear in several EEG channels during an otherwise stable recording. Their timing precisely tracks the ECG complexes. Recognize cardiac contamination before interpreting them as a train of cortical spikes or escalating treatment.
Common pitfall: A sharply contoured waveform is not necessarily epileptiform; overlooking its fixed cardiac timing can convert a technical artifact into a misleading epilepsy diagnosis or treatment decision.
22.How should background findings and montage-dependent EEG polarity be interpreted?
First establish age, wakefulness or sleep, medication exposure, and technical quality. Assess the posterior dominant rhythm with eye opening and closure, symmetry, continuity, and reactivity. Persistent focal slowing supports regional cerebral dysfunction but does not identify its cause or independently prove epilepsy. Generalized slowing supports diffuse dysfunction when inappropriate for age and state. Drowsiness-related slowing and sharply contoured normal variants require different interpretation from pathological slowing or epileptiform discharges. Each EEG channel displays the first electrode's potential minus the second electrode's potential. Using conventional negative-up display, a negative difference deflects upward and a positive difference downward. For simultaneous potentials F7 = −20 µV, T7 = −80 µV, P7 = −20 µV, and reference R = 0 µV, bipolar F7−T7 is +60 µV downward and T7−P7 is −60 µV upward: a phase reversal identifies a negative field maximum at T7. Referential F7−R, T7−R, and P7−R are −20, −80, and −20 µV, all upward with the largest negativity at T7. If R instead carries −60 µV, those referential channels become +40, −20, and +40 µV, changing their apparent polarity while the bipolar differences remain unchanged. Activity at the reference is subtracted into every channel sharing it. ACNS therefore recommends both bipolar and referential interpretation and changing a contaminated reference.
Apply it
An awake adult has persistent left temporal slowing without spikes: report regional dysfunction and correlate with imaging and history. Separately, if F7, T7, and P7 are each 0 µV while R has a −60-µV transient, all three referential channels show +60 µV downward, but F7−T7 and T7−P7 are 0 µV. Infer shared-reference contamination rather than three independent scalp discharges. Compare alternative references and the full field before assigning localization.
Common pitfall: Skipping the background can miss dysfunction, while ignoring state can misclassify normal sleep changes. A bipolar phase reversal marks a field extremum, not independently the seizure-onset zone. Reference activity, cancellation, and volume conduction require localization to be checked across montages.
ABPN Epilepsy Certification Content Specifications — December 2025 · ACNS Guideline 7 — Guidelines for EEG Reporting · EEGGuideline3Montage_final20160323revclean_v1.pdf
23.How should CSF sampling and glucose results be interpreted in suspected GLUT1 deficiency?
Perform lumbar puncture after a four- to six-hour fast and measure blood glucose immediately before the procedure to avoid distortion by stress-related hyperglycemia. Typical disease often produces marked hypoglycorrhachia, historically below 40 mg/dL, but milder presentations may have CSF glucose around 41–52 mg/dL. CSF lactate is low or low-normal. Consider age-specific ranges and exclude competing causes such as systemic hypoglycemia, meningitis, subarachnoid hemorrhage, and ventricular shunt-related abnormalities. No single CSF-to-blood glucose ratio is an absolute exclusion threshold.
Apply it
A child with exertional dyskinesia has fasting CSF glucose of 46 mg/dL, normal immediately preceding blood glucose, and low-normal CSF lactate. This result can support a mild GLUT1 phenotype and warrants integration with clinical findings and SLC2A1 analysis.
Common pitfall: Rejecting GLUT1 deficiency because CSF glucose exceeds 40 mg/dL or a ratio exceeds one cutoff can miss milder disease. Unpaired or poorly timed samples can also mislead.
24.Why can fragmented generalized discharges resemble focal spikes in JME?
Generalized spike-wave or polyspike-wave discharges in juvenile myoclonic epilepsy may fragment and appear focal or multifocal, especially during sleep. Their morphology and relationship to generalized bursts help prevent false localization. Persistently focal abnormalities or a consistent focal clinical history deserve separate scrutiny, but an isolated fragment should not outweigh the overall electroclinical pattern. Review the entire recording and seizure history before reclassifying an otherwise convincing generalized epilepsy as focal on the basis of one discharge.
Apply it
A teenager with morning bilateral myoclonus has generalized polyspike-wave bursts and occasional short frontal fragments. Interpret the fragments within the complete recording instead of declaring a separate frontal epilepsy from their limited distribution.
Common pitfall: Overweighting a single focal-looking fragment can obscure a generalized epilepsy syndrome; equally, genuinely consistent focal findings should not be dismissed without reviewing the full clinical context.
ILAE EpilepsyDiagnosis.org — Juvenile Myoclonic Epilepsy: EEG
25.What makes an absence diagnosis electroclinical?
A typical absence combines an abrupt clinical interruption of awareness or responsiveness with characteristic generalized spike-wave activity, commonly around 3 Hz in childhood absence epilepsy. Behavioral testing is useful because short discharges may have subtle effects and staring can have nonepileptic causes. The diagnosis therefore depends on the relationship between the electrical pattern and the event, alongside the syndrome history. A generalized discharge without demonstrated clinical impairment should be described accurately rather than automatically equated with every reported staring spell.
Apply it
A child stops counting mid-sequence during a generalized spike-wave burst and immediately resumes afterward. The time-linked interruption provides stronger evidence for an absence seizure than a caregiver's description of occasional inattentiveness alone.
Common pitfall: Staring alone is nonspecific, while an interictal generalized discharge does not establish that every reported pause is an absence; match the habitual behavior to the recording.
Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy · Routine-and-sleep-EEG-Minimum-recording-standards-of-the-internationa-federation-of-clinical-neurophysiology-and-the-international-league-against-epilepsy.pdf
26.How do sleep sampling and historical EEG establish the Lennox-Gastaut EEG criteria?
The required EEG profile comprises generalized slow spike-wave below 2.5 Hz and generalized paroxysmal fast activity at least 10 Hz in sleep. Sleep sampling is therefore essential to assess the fast-activity criterion. In adults, slow spike-wave may no longer be apparent; historical recordings can establish its earlier presence. Interpret these mandatory EEG findings alongside tonic seizures and at least one additional qualifying seizure type rather than treating either EEG pattern alone as a complete syndrome diagnosis.
Apply it
An adult with childhood-onset drug-resistant epilepsy has nocturnal tonic seizures and sleep-related generalized 15-Hz fast bursts. Review childhood EEG for generalized spike-wave below 2.5 Hz when the current waking recording lacks that pattern.
Common pitfall: A wake-only EEG incompletely assesses the required sleep pattern. Absence of current slow spike-wave in adulthood does not erase well-documented historical evidence.
LENNOX-GASTAUT SYNDROME (LGS) · ILAE EpilepsyDiagnosis.org — Lennox-Gastaut Syndrome: EEG
27.How does hypsarrhythmia differ from an ictal spasm pattern?
Hypsarrhythmia is an interictal pattern characterized by markedly disorganized, high-amplitude activity with multifocal epileptiform abnormalities. An individual epileptic spasm may instead have an ictal EEG change such as a slow wave followed by attenuation or fast activity. These findings answer different questions: the background pattern characterizes interictal organization, while event-linked change supports the nature of a captured spell. Evaluate sleep and habitual events because classic hypsarrhythmia is not present in every infant with epileptic spasms.
Apply it
Monitoring captures an infant's habitual brief flexor event with a time-linked slow wave and attenuation, although the intervening background is not classically hypsarrhythmic. Interpret the captured event directly rather than rejecting it because of the background.
Common pitfall: Confusing an interictal syndrome-associated pattern with the required appearance of every individual seizure can cause a clearly captured spasm to be incorrectly dismissed during interpretation.
ILAE EpilepsyDiagnosis.org — Infantile Epileptic Spasms Syndrome: EEG
28.Which patterns meet the ACNS electrographic seizure definition, and how do definite evolution and fluctuation differ?
ACNS 2021 defines an electrographic seizure as epileptiform discharges averaging more than 2.5 Hz for at least 10 seconds, or any definitely evolving pattern lasting at least 10 seconds. Frequency evolution requires at least two consecutive changes in the same direction, each by at least 0.5 Hz, with each frequency persisting for at least three cycles. Morphological evolution requires at least two consecutive changes to novel morphologies, each persisting for at least three cycles. Spatial evolution requires sequential spread into, or sequential withdrawal from, at least two different standard 10–20 electrode locations, each involved for at least three cycles. For each route, the qualifying changes must develop without the evolving feature remaining unchanged for five or more continuous minutes. Fluctuation requires at least three changes in frequency, morphology, or location, no more than one minute apart, without qualifying as evolution. Frequency changes must be at least 0.5 Hz; location changes must span at least one standard interelectrode distance. Each frequency, morphology, or location must persist for at least three cycles. Amplitude change alone establishes neither evolution nor fluctuation.
Apply it
A continuous rhythmic pattern at 1 Hz for four seconds, 1.5 Hz for four seconds, and 2 Hz for four seconds qualifies through evolution: two consecutive 0.5-Hz increases, at least three cycles at each frequency, no five-minute plateau, and 12 seconds total. Conversely, 1 Hz for one minute, 1.5 Hz for six minutes, then 2 Hz for one minute fails the evolution route because the intermediate frequency remains unchanged for six continuous minutes; assume no independent morphological or spatial evolution. A sequence of 1→1.5→1→1.5 Hz, with each frequency lasting four seconds, meets fluctuation criteria: three qualifying changes within one-minute intervals, with each frequency sustained for at least three cycles, but no two consecutive changes in the same direction. Independently, 3-Hz epileptiform discharges sustained for 14 seconds meet the frequency route without evolution.
Common pitfall: Exactly 2.5 Hz does not exceed the seizure frequency threshold. A single frequency change, amplitude increase, or prolonged plateau between otherwise adequate changes does not establish definite evolution. Count changes separately from frequency states: four successive states produce three changes. Fluctuation alone does not establish an electrographic seizure. A definite time-locked clinical correlate can establish an electroclinical seizure even when the EEG pattern lasts less than 10 seconds.
ACNS Standardized Critical Care EEG Terminology — 2021 Version
29.How is electrographic status epilepticus quantified?
ACNS defines electrographic status epilepticus as an electrographic seizure lasting at least 10 continuous minutes or electrographic seizures occupying at least 20% of any 60-minute recording period. The burden route allows recurrent separated seizures to qualify even without a single 10-minute event. Calculate actual seizure time rather than simply counting episodes. These EEG criteria must be distinguished from the earlier clinical treatment threshold used for an ongoing convulsive seizure in emergency care.
Apply it
Twelve electrographic seizures each last 70 seconds within one hour. Their total is 840 seconds, or 14 minutes, exceeding the 12 minutes required for 20% hourly burden despite no prolonged individual seizure.
Common pitfall: Counting events instead of total seizure duration can misclassify status; the five-minute convulsive treatment threshold and ACNS electrographic status definition address different operational decisions in clinical practice.
ACNS Standardized Critical Care EEG Terminology — 2021 Version
30.Which patterns qualify for the ACNS ictal-interictal continuum?
For patterns not meeting electrographic seizure or status criteria, IIC includes periodic discharges or spike-wave averaging above 1 through 2.5 Hz over 10 seconds. At 0.5–1 Hz, these patterns require fluctuation or a plus modifier. Lateralized rhythmic delta above 1 Hz for at least 10 seconds also requires fluctuation or a plus modifier; generalized rhythmic delta alone does not qualify by this route. IIC is an electrographic designation requiring clinical interpretation. The 2021 critical-care terminology excludes neonates.
Apply it
An encephalopathic adult has nonevolving 0.75-Hz lateralized periodic discharges with superimposed fast activity for 30 seconds. The plus-fast modifier makes this an IIC pattern despite its frequency being below 1 Hz.
Common pitfall: Periodicity alone does not establish IIC or status. A nonevolving 0.75-Hz periodic pattern without fluctuation or a plus modifier does not meet these IIC criteria.
ACNS Standardized Critical Care EEG Terminology — 2021 Version
31.When can an electroclinical seizure last less than 10 seconds?
Under ACNS terminology, an EEG pattern with a definite time-locked clinical correlate can qualify as an electroclinical seizure regardless of its duration. This differs from the duration requirement for an electrographic seizure defined without a clinical correlate. The observed sign must be convincingly linked to the pattern rather than merely occurring nearby by chance. Careful synchronized observation is therefore essential when evaluating brief repetitive motor or behavioral changes in a monitored patient.
Apply it
A reproducible six-second EEG pattern accompanies a precisely time-locked focal facial movement on every occurrence. The short duration does not exclude an electroclinical seizure when the relationship between the clinical sign and EEG is definite.
Common pitfall: Applying the 10-second electrographic threshold to every event overlooks the separate electroclinical definition; loosely associated movement, however, is insufficient to establish a definite clinical correlate.
ACNS Standardized Critical Care EEG Terminology — 2021 Version
32.What do lateralized periodic discharges tell you about etiology?
Lateralized periodic discharges describe the spatial distribution and recurrence of an EEG pattern; they do not identify a single disease. Assessment should include frequency, evolution, modifiers, background, and clinical context. Stroke, infection, and neoplasm remain distinct etiologic considerations in an appropriate patient, requiring their own history, imaging, and laboratory evidence. A standardized EEG label organizes the observed physiology while preserving the need to determine why the affected cerebral region is abnormal in that individual.
Apply it
A patient with new confusion has lateralized periodic discharges. Use the EEG to characterize the pattern and seizure concern while pursuing the clinical and imaging evidence that distinguishes vascular, infectious, neoplastic, and other causes.
Common pitfall: Treating lateralized periodic discharges as a disease-specific signature can prematurely close the differential; a physiological pattern cannot replace etiologic evidence from the rest of the assessment.
ACNS Standardized Critical Care EEG Terminology — 2021 Version · ABPN Epilepsy Certification Content Specifications — December 2025
33.Which MRI findings support hippocampal sclerosis?
Hippocampal sclerosis is supported by hippocampal volume loss and increased T2 or FLAIR signal, interpreted using an appropriate epilepsy imaging protocol. Optimized views help evaluate hippocampal structure and distinguish a true abnormality from inadequate sampling or orientation. Imaging supports a structural hypothesis but must be correlated with seizure semiology and electrophysiology. An abnormal hippocampus alone does not establish that every event arises there or prove that resection will provide an acceptable benefit-risk balance.
Apply it
A patient with focal seizures has a smaller hippocampus with increased FLAIR signal on dedicated imaging. Compare the lesion's side with the clinical and EEG findings before using it to support a presurgical localization hypothesis.
Common pitfall: Relying on signal change alone or assuming any visible lesion is the seizure source bypasses the structural and electroclinical concordance needed for a defensible interpretation.
34.Why look for dual pathology when hippocampal sclerosis is present?
Hippocampal sclerosis can coexist with another potentially relevant lesion, a situation termed dual pathology. Identifying one abnormality should therefore not end systematic review of an epilepsy MRI. A second lesion may alter the localization hypothesis and the questions asked during presurgical evaluation. The decision is not that every second finding requires treatment, but that the full structural picture must be reconciled with clinical and EEG evidence before a surgical strategy is selected.
Apply it
Dedicated MRI confirms hippocampal sclerosis but also reveals a separate cortical abnormality. Reassess the complete electroclinical hypothesis and discuss how both findings affect the evaluation rather than planning treatment from the hippocampal lesion alone.
Common pitfall: Stopping image review after finding hippocampal sclerosis can miss a second relevant abnormality; conversely, detecting two lesions does not establish that both independently generate seizures.
35.What can presurgical language fMRI establish?
Language fMRI can assist presurgical language lateralization in selected epilepsy patients and may be considered as an alternative to intracarotid amobarbital testing in specified settings. Its interpretation depends on the task, patient performance, analysis, and clinical context. Lateralization is different from defining every indispensable language site or guaranteeing freedom from postoperative language decline. Discordant or technically limited results should be integrated with other presurgical evidence rather than treated as a definitive map of safe resection boundaries.
Apply it
A surgical candidate has a language fMRI report showing left dominance but poor task performance. Review technical validity and the proposed operation's risks before relying on that result as sufficient evidence for an individual language-safety decision.
Common pitfall: Confusing hemispheric lateralization with precise essential-cortex localization overstates fMRI and can produce an unsupported promise about postoperative language function for an individual surgical candidate undergoing evaluation.
AAN Clinician Summary — Use of fMRI in Presurgical Epilepsy Evaluation
Treatment/Management31-39%
36.Why is ethosuximide a strong initial choice for pure childhood absence epilepsy?
In the randomized childhood absence epilepsy trial, ethosuximide and valproic acid were more effective than lamotrigine on the study's freedom-from-treatment-failure outcome. Attentional dysfunction was more frequent with valproic acid than ethosuximide, supporting ethosuximide as a strong initial option when absence seizures are the relevant seizure type. The decision depends on a correct syndrome and seizure inventory. Results in this defined population should not be generalized to all generalized epilepsies or mixed seizure presentations.
Apply it
A child with newly diagnosed childhood absence epilepsy has typical absences without myoclonic or tonic-clonic seizures. Discuss ethosuximide using the trial's effectiveness and attention findings while confirming there is no other seizure type needing coverage.
Common pitfall: Calling ethosuximide universally preferable for generalized epilepsy extends a syndrome-specific result beyond the studied population and overlooks its limited suitability when other seizure types coexist clinically.
Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
37.How should maintenance selection change when generalized epilepsy includes convulsions?
An absence-specific drug cannot provide the required coverage when generalized tonic-clonic seizures coexist. Ethosuximide labeling cautions that monotherapy in mixed epilepsy may increase tonic-clonic seizure frequency in some patients. Compare broad-spectrum options using syndrome effectiveness and individual risks. In [SANAD II's generalized and unclassifiable epilepsy trial](https://pmc.ncbi.nlm.nih.gov/articles/PMC8047813/), levetiracetam did not establish noninferiority to valproate for time to 12-month remission, and the per-protocol analysis favored valproate. Valproate can therefore be a strong efficacy choice when suitable, but reproductive risks may favor an alternative such as levetiracetam after individualized review.
Apply it
An adult man with generalized spike-wave has absences and recurrent generalized tonic-clonic seizures. With no relevant contraindication, valproate is a defensible broad-spectrum choice. For a patient who may become pregnant, explicitly weigh that efficacy against fetal risks rather than automatically applying the same selection.
Common pitfall: Improved staring spells do not establish overall seizure control. Neither a comparative efficacy result nor a reproductive safety preference establishes one universally best drug.
DailyMed — Ethosuximide Oral Solution Prescribing Information · AAN, AES, and SMFM — Guideline Issued for People with Epilepsy Who May Become Pregnant
38.Why does valproate change lamotrigine initiation, and what is a worked regimen?
Valproate inhibits lamotrigine glucuronidation, reducing clearance and increasing exposure. For immediate-release lamotrigine adjunctive epilepsy treatment in patients older than 12 years taking valproate, the label starts with 25 mg every other day during weeks 1–2, then 25 mg daily during weeks 3–4. Thereafter, increase the daily dose by 25–50 mg every 1–2 weeks as indicated. Excessive starting doses and rapid escalation increase serious rash risk. This example does not supply a pediatric regimen or a universal maintenance target: younger children require weight-based schedules, and maintenance depends on the full interacting regimen.
Apply it
A 17-year-old taking valproate is prescribed immediate-release lamotrigine as adjunctive treatment. Start 25 mg every other day for two weeks, then 25 mg daily for two weeks, before the specified gradual increases; do not copy a schedule intended for patients without valproate.
Common pitfall: The dose increases are increments in total daily dose, not instructions to increase by that amount every day. Do not apply this older-than-12-years example to younger children or extended-release products.
39.How do rash and treatment interruption change lamotrigine management?
Labeling advises discontinuing lamotrigine at the first sign of rash unless clearly unrelated because early appearance cannot reliably distinguish benign from serious reactions. Mucosal or systemic findings require urgent assessment. After interruption exceeding five half-lives, the initial titration generally must be followed again; interacting medicines change that interval. A previous rash-related discontinuation is a separate issue: restarting requires a judgment that potential benefits clearly outweigh risks rather than routine resumption.
Apply it
A patient reports a new rash after escalation, while another requests a full-dose restart after a prolonged interruption. Apply the rash discontinuation precaution to the first and assess interruption length, interactions, and renewed titration for the second.
Common pitfall: Waiting for a severe rash or restarting a maintenance dose after a long gap bypasses the safety precautions. A fixed number of missed days cannot replace interaction-dependent half-life assessment.
40.How should comparative evidence guide maintenance selection for newly diagnosed focal epilepsy?
Confirm focal epilepsy before choosing maintenance treatment, then weigh comparative effectiveness, tolerability, interactions, and initiation speed. [SANAD II's focal epilepsy trial](https://pubmed.ncbi.nlm.nih.gov/33838757/) supports lamotrigine as a first-line option compared with levetiracetam and zonisamide. This supports a treatment policy rather than proving that every individual should receive lamotrigine. Its gradual titration can be a practical disadvantage when rapid coverage is needed, whereas rash history or interacting medicines may change suitability. Ethosuximide supplies absence coverage rather than focal-seizure treatment. A maintenance choice also does not replace a separate rescue plan for prolonged convulsions.
Apply it
An adult with newly diagnosed focal epilepsy has no prior serious rash, no relevant interacting drugs, and no immediate need for rapid loading. Lamotrigine is a defensible initial maintenance choice. Explain its titration and adverse-effect precautions, then separately specify rescue treatment if prolonged convulsions are a concern.
Common pitfall: Do not transfer generalized-epilepsy comparative results to focal epilepsy or assume that rapid initiation establishes superior long-term effectiveness. Review product-specific monotherapy and adjunctive labeling separately from trial evidence.
DailyMed — Lamotrigine Prescribing Information · DailyMed — Ethosuximide Oral Solution Prescribing Information · AES — Guideline for Treatment of Prolonged Seizures in Children and Adults
41.How can estrogen-containing contraception affect lamotrigine exposure?
Estrogen-containing oral contraceptives can increase lamotrigine clearance and lower concentrations; stopping estrogen can increase exposure. Levels may also rise during an inactive-pill interval. These changes can affect seizure control or adverse effects and may require adjustment using labeling and clinical monitoring. Starting or stopping contraception should therefore trigger medication review. The interaction should be considered separately from initial rash-prevention titration, and dosing decisions must account for other medicines that also alter lamotrigine metabolism.
Apply it
A patient controlled on lamotrigine starts estrogen-containing contraception and later reports breakthrough seizures. Review adherence, timing, interacting medicines, and the exposure change before concluding that the epilepsy has newly become intrinsically drug resistant.
Common pitfall: Changing contraception without revisiting lamotrigine can alter exposure in either direction; an unchanged tablet dose does not guarantee an unchanged effective concentration or clinical response.
42.When and at what initial dose should continuing convulsions receive IV lorazepam?
Begin benzodiazepine treatment when convulsions continue for five minutes, while airway support, oxygenation, monitoring, vascular access, and bedside glucose assessment proceed. With IV access, the AES algorithm gives lorazepam 0.1 mg/kg IV, maximum 4 mg per dose; the full dose may be repeated once if seizures persist. Give an adequate initial dose rather than multiple small fractions that delay effective treatment. Correct hypoglycemia promptly when present, but do not postpone seizure treatment for imaging, EEG, or an extensive etiologic workup.
Apply it
A 70-kg adult has continuous convulsions at six minutes. Give 4 mg IV lorazepam with respiratory monitoring and support; if seizures persist, the dose may be repeated once while preparing second-line treatment.
Common pitfall: The five-minute clinical treatment threshold differs from ACNS electrographic status criteria. Respiratory support must be available, but concern about benzodiazepines should not produce untreated prolonged convulsions.
AES — Guideline for Treatment of Prolonged Seizures in Children and Adults
43.How should unavailable IV access affect initial status treatment?
Do not delay initial benzodiazepine treatment while repeatedly attempting IV access. The AES algorithm supports IM midazolam: 10 mg for patients weighing more than 40 kg, or 5 mg for those weighing 13–40 kg, as a single initial dose. These weight bands do not supply a regimen for smaller children. Continue stabilization and establish access while the deliverable initial treatment takes effect.
Apply it
Paramedics encounter a 65-kg adult with continuing convulsions beyond five minutes and no IV access. Give 10 mg IM midazolam while providing emergency support and preparing subsequent treatment.
Common pitfall: Do not substitute the adult fixed dose for every child or treat IV access as a prerequisite for effective initial therapy.
AES — Guideline for Treatment of Prolonged Seizures in Children and Adults
44.Which loading regimens, contraindications, and escalation steps apply after adequate benzodiazepines fail?
For benzodiazepine-refractory convulsive status, ESETT studied IV levetiracetam 60 mg/kg, maximum 4,500 mg; fosphenytoin 20 mg PE/kg, maximum 1,500 mg PE; or valproate 40 mg/kg, maximum 3,000 mg, each infused over 10 minutes. PE denotes phenytoin equivalents. ESETT enrolled patients aged at least two years and found no clear efficacy winner. Treatment selection must exclude contraindicated drugs. Valproate is contraindicated with hepatic disease or significant hepatic dysfunction, known POLG-related mitochondrial disease, known urea-cycle disorders, or hypersensitivity; suspected POLG-related disease in children under two is also a contraindication. Fosphenytoin is contraindicated with sinus bradycardia, sinoatrial block, second- or third-degree AV block, or Adams-Stokes syndrome. Other labeled exclusions include hydantoin hypersensitivity, prior acute hepatotoxicity attributable to phenytoin or fosphenytoin, and delavirdine coadministration. Hypotension and severe myocardial insufficiency heighten fosphenytoin cardiovascular risk and require precautions; the named conduction disorders are contraindications rather than merely reasons for closer observation. Continuously monitor ECG, blood pressure, and respiratory function during IV fosphenytoin and afterward through the peak-concentration period, approximately 10–20 minutes after infusion. Do not exceed 150 mg PE/min in adults or 2 mg PE/kg/min in children, capped at 150 mg PE/min. Cardiovascular toxicity can occur within these limits. Consider renal function for subsequent levetiracetam dosing. Persistent convulsions after an adequate benzodiazepine and second-line load constitute refractory status: urgently involve intensive care and anesthesia, secure ventilation as needed, and begin anesthetic treatment such as midazolam or propofol with continuous EEG.
Apply it
A 70-kg adult continues convulsing after adequate lorazepam and has known POLG disease and second-degree AV block. Exclude valproate and fosphenytoin, respectively. An ESETT levetiracetam load is 4,200 mg IV over 10 minutes. If seizures continue after the load, proceed urgently to refractory-status management and continuous EEG rather than waiting for the trial's one-hour outcome assessment.
Common pitfall: Fosphenytoin is prescribed in mg PE. Monitoring cannot make a contraindicated drug appropriate, and a slower infusion does not remove a conduction contraindication. ESETT loading regimens do not establish universal suitability or replace product precautions. Paralysis can conceal continuing electrical seizures.
Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial - PMC · AES — Guideline for Treatment of Prolonged Seizures in Children and Adults · ACNS Standardized Critical Care EEG Terminology — 2021 Version · These highlights do not include all the information needed to use VALPROATE SODIUM INJECTION safely and effectively. See full prescribing information for VALPROATE SODIUM INJECTION. VALPROATE SODIUM injection, for intravenous injectionInitial U.S. Approval: 1996 · DailyMed - FOSPHENYTOIN SODIUM injection, solution
45.How do treatment choices differ for infantile spasms and Lennox-Gastaut syndrome?
For confirmed infantile spasms, initiate syndrome-specific treatment promptly. The [2022 neuropediatric society guideline](https://pmc.ncbi.nlm.nih.gov/articles/PMC9643068/) recommends hormonal treatment with ACTH or prednisolone, alone or combined with vigabatrin; vigabatrin is the first choice with tuberous sclerosis or contraindications to hormonal treatment. Assess clinical and EEG response after about 14 days. Lennox-Gastaut syndrome requires coverage of its multiple seizure types. An [updated expert consensus algorithm](https://pubmed.ncbi.nlm.nih.gov/39700524/) places valproate first, followed when needed by adjunctive lamotrigine and then rufinamide. That sequence is expert guidance, not proof of universal superiority. Apply valproate-specific lamotrigine titration and assess reproductive risks, sedation, and functional outcomes.
Apply it
An infant with tuberous sclerosis and electroclinically confirmed spasms should receive vigabatrin-focused treatment rather than a routine focal-epilepsy titration. A child with Lennox-Gastaut syndrome and continuing tonic and drop seizures on valproate may warrant carefully titrated adjunctive lamotrigine, with subsequent options selected from response and tolerability.
Common pitfall: Fewer spasms do not necessarily mean complete electroclinical response. In Lennox-Gastaut syndrome, improvement in one seizure type can coexist with continued injury-producing events or excessive treatment-related sedation.
ILAE EpilepsyDiagnosis.org — Infantile Epileptic Spasms Syndrome: EEG · LENNOX-GASTAUT SYNDROME (LGS) · DailyMed — Lamotrigine Prescribing Information
46.Why should antiseizure medication not be stopped abruptly after pregnancy is recognized?
Pregnancy does not remove the need to prevent clinically important seizures, especially convulsive seizures that can endanger the pregnant person and fetus. The AAN, AES, and SMFM guidance warns against stopping or changing antiseizure medication without medical advice after pregnancy is recognized. Management balances fetal medication risks against seizure risks using the individual's seizure history and current regimen. Prompt review is appropriate, but an unsupervised abrupt interruption is not a protective substitute for a coordinated treatment plan.
Apply it
A newly pregnant patient taking medication for prior tonic-clonic seizures wants to stop immediately after reading about malformations. Explain the risk of loss of seizure control and arrange prompt individualized review while avoiding an abrupt unsupervised interruption.
Common pitfall: Framing fetal medication exposure as the only relevant risk ignores the consequences of recurrent convulsive seizures and can encourage a harmful abrupt withdrawal during pregnancy itself.
AAN, AES, and SMFM — Guideline Issued for People with Epilepsy Who May Become Pregnant
47.When should pregnancy-related medication optimization and folic acid counseling occur?
Optimize medication before pregnancy whenever feasible, considering seizure control and fetal risks together. The 2024 AAN, AES, and SMFM guidance identifies lamotrigine, levetiracetam, and oxcarbazepine as options to consider when appropriate and recommends avoiding valproic acid when clinically feasible because of fetal risks. Suitability still depends on epilepsy type and treatment history. Recommend at least 0.4 mg folic acid daily before and during pregnancy for people taking an antiseizure medication. Supplementation complements treatment planning; it does not eliminate fetal risks or establish one universally optimal higher dose.
Apply it
A patient planning pregnancy requests review several months before conception. Compare syndrome suitability, prior response, and reproductive risks, begin the recommended minimum folic acid intake, and allow time to assess any planned medication change.
Common pitfall: Choosing solely by reproductive risk can sacrifice seizure control. Folic acid does not substitute for antiseizure medication, and waiting until pregnancy is established can make optimization more difficult.
AAN, AES, and SMFM — Guideline Issued for People with Epilepsy Who May Become Pregnant
48.How do localization, concordance, and functional risk determine the next presurgical step?
Reconcile habitual seizure semiology, ictal video-EEG, epilepsy-protocol MRI, and neuropsychological findings. Concordant unilateral temporal evidence can support consideration of resection or selected ablation when functional risk is acceptable. Discordant sides or uncertain mesial versus neocortical onset require a testable localization hypothesis before intracranial monitoring; stereo-EEG samples proposed networks rather than surveying the entire brain. Dominant temporal treatment requires explicit language and memory-risk assessment. If the epileptogenic region cannot be treated safely, consider neuromodulation rather than assuming lesion removal is appropriate. See the [ILAE educational seminar on presurgical evaluation](https://www.uniklinik-freiburg.de/fileadmin/mediapool/07_kliniken/nch_praechirurgische-epi/PDF_2025/Epileptic_Disorders_2025_Schuele.pdf).
Apply it
Drug-resistant seizures have a consistent right temporal ictal onset, right hippocampal sclerosis, and compatible semiology. After neuropsychological and functional assessment, discuss temporal resection versus selected mesial ablation. If habitual seizures instead show left temporal onset, resolve the discordance before a right-sided destructive procedure.
Common pitfall: A lesion is not a complete surgical plan. Smaller ablation does not guarantee equal seizure control or freedom from cognitive injury, and language lateralization alone does not measure memory reserve.
ILAE EpilepsyDiagnosis.org — Hippocampal Sclerosis: Imaging · AAN Clinician Summary — Use of fMRI in Presurgical Epilepsy Evaluation · ILAE Surgical Therapies Commission — Timing of Referral for Epilepsy Surgery (2022)
49.When should drug-resistant epilepsy prompt comprehensive surgical evaluation?
Drug resistance means failure of two tolerated, appropriately chosen and used medication schedules, alone or in combination, to achieve sustained seizure freedom. Confirm event diagnosis, seizure coverage, adherence, and trial adequacy. Once established, offer timely comprehensive evaluation; a normal routine MRI does not preclude referral. Evaluation reviews localization, imaging, cognition, and treatment options. It does not commit the patient to surgery or guarantee a curative procedure.
Apply it
Verified focal seizures continue after two adequate medication schedules despite a normal routine MRI. Refer for comprehensive evaluation while continuing medical care, explaining that a procedure would require a separate informed decision.
Common pitfall: Counting inappropriate prescriptions can overstate drug resistance. Requiring numerous additional failures or a visible lesion can delay useful evaluation after genuine drug resistance is established.
ILAE Surgical Therapies Commission — Timing of Referral for Epilepsy Surgery (2022)
50.How should a new focal deficit after a seizure change vascular management?
A seizure and a cerebrovascular event can coexist, so new persistent weakness, aphasia, or altered consciousness should trigger urgent assessment for ischemia or hemorrhage rather than automatic attribution to a postictal state. Establish onset and baseline, check glucose, and select acute structural and vascular imaging for the suspected process. CT addresses an urgent hemorrhage question; MRI with diffusion-weighted imaging and vascular studies can address other unresolved vascular questions. Treat ongoing seizures in parallel.
Apply it
A patient with prior epilepsy develops sustained aphasia after a convulsion. Compare with previous recovery patterns and initiate acute vascular assessment rather than waiting for presumed postictal aphasia to resolve.
Common pitfall: A known epilepsy diagnosis does not explain every new deficit. An EEG abnormality also does not exclude a simultaneous infarct, hemorrhage, or other vascular lesion.
ABPN Epilepsy Certification Content Specifications — December 2025 · AES — Guideline for Treatment of Prolonged Seizures in Children and Adults
51.What immediate treatment is required when seizures suggest infectious encephalitis?
New seizures with fever, amnesia, or sustained behavioral or cognitive change warrant prompt empirical IV acyclovir while MRI, CSF studies, and other diagnostic investigations proceed. Do not wait for HSV PCR confirmation. Assess renal function and adjust dosing appropriately; for adults with normal renal function, the IDSA guideline uses acyclovir 10 mg/kg IV every eight hours. Temporal periodic discharges support concern for regional dysfunction but do not establish HSV infection. If initial CSF HSV PCR is negative and the syndrome or temporal imaging remains compatible, repeat testing in 3–7 days while maintaining appropriate empirical treatment.
Apply it
A febrile adult develops new seizures, amnesia, and temporal periodic discharges. Begin IV acyclovir promptly, assess renal function, obtain MRI and CSF when safe, and investigate other infectious and immune causes. An early negative HSV PCR does not by itself justify stopping treatment.
Common pitfall: Neither a temporal EEG pattern nor an initial negative PCR settles the etiology. An imaging or lumbar-puncture delay should not delay empirical acyclovir; add other empirical antimicrobials when the clinical differential requires them.
DownloadAsset.aspx · ACNS Standardized Critical Care EEG Terminology — 2021 Version
52.How does responsive neurostimulation deliver treatment?
Responsive neurostimulation uses implanted electrodes to monitor electrocorticographic activity and deliver electrical stimulation when programmed detection criteria are met. Cortical or depth leads connect the sensing and stimulation system to selected brain regions. This is a detection-triggered treatment mechanism rather than removal of epileptogenic tissue. It is adjunctive treatment requiring continued seizure assessment, programming, and medication review rather than automatic medication withdrawal. Stable mechanisms should be distinguished from model-specific restrictions that change with current labeling.
Apply it
A patient expects the device to remove abnormal tissue and replace all medication. Explain electrical sensing and responsive stimulation, its adjunctive role, and the continuing need for coordinated follow-up.
Common pitfall: Implantation does not guarantee seizure freedom. A detected electrical pattern is also not automatically a clinical seizure, and restrictions from an older manual may not apply to current hardware.
FDA Product Classification — Implanted Brain Stimulator for Epilepsy · FDA-Hosted NeuroPace RNS System Patient Manual — Original Approval-Era Document
53.How should tumor-related epilepsy change antiseizure medication selection?
Strong enzyme-inducing antiseizure medications, including phenytoin, carbamazepine, and phenobarbital, can increase clearance of susceptible antineoplastic drugs and corticosteroids by inducing hepatic drug-metabolizing enzymes. The [SNO consensus review](https://pmc.ncbi.nlm.nih.gov/articles/PMC10768995/) therefore supports preferring a non-enzyme-inducing option when appropriate. Levetiracetam is often selected because of limited pharmacokinetic interactions and rapid initiation, although irritability and mood effects may alter that choice. Phenytoin can increase dexamethasone clearance, reducing exposure. Review the actual oncology regimen rather than assuming every antineoplastic drug shares the same interaction. Worsening seizures require imaging and clinical reassessment but do not independently prove progression.
Apply it
A patient receiving dexamethasone and a susceptible CYP-metabolized antineoplastic drug needs treatment for focal seizures. Prefer a suitable non-enzyme-inducing option over carbamazepine or phenytoin after reviewing mood, renal function, and other adverse-effect risks.
Common pitfall: Do not equate seizure worsening with proven tumor growth or infer an interaction solely from a drug's oncology indication. Coordinate any medication transition with seizure coverage and tumor-directed treatment.
ABPN Epilepsy Certification Content Specifications — December 2025
54.How should persistent cognitive change after seizures be managed?
Establish the patient's baseline and the time course before assigning persistent confusion or memory impairment to epilepsy. Ongoing nonconvulsive seizures, medication effects, metabolic illness, and a separate cognitive disorder require different responses. EEG addresses ongoing electrical seizure activity; it does not replace assessment of systemic causes. Once the acute state is stable, neuropsychological testing can distinguish attention, memory, language, executive, and visuospatial deficits and guide medication review, rehabilitation, and presurgical counseling.
Apply it
An older adult remains confused beyond their usual recovery interval. Assess for ongoing seizures and reversible medical or medication contributors. If memory problems persist after stabilization, obtain structured cognitive evaluation rather than diagnosing dementia from an acute bedside encounter.
Common pitfall: Generalized slowing does not independently diagnose dementia, and poor testing during delirium cannot be assumed to represent the person's stable cognitive ability.
ABPN Epilepsy Certification Content Specifications — December 2025 · ACNS Standardized Critical Care EEG Terminology — 2021 Version · Routine-and-sleep-EEG-Minimum-recording-standards-of-the-internationa-federation-of-clinical-neurophysiology-and-the-international-league-against-epilepsy.pdf
55.How should depression and anxiety be addressed separately from seizure diagnosis?
Assess sustained low mood, loss of interest, excessive worry, functional impairment, and safety directly rather than assuming distress is explained by seizure frequency. Establish the relationship to seizures, medication changes, sleep, and psychosocial circumstances. Depression or anxiety can require treatment even when seizures are controlled or functional events coexist. Ask about suicidal thinking and arrange urgent assessment when immediate risk is identified. Coordinate psychological and medication treatment with epilepsy care and review interactions and adverse effects.
Apply it
A seizure-free patient reports persistent anhedonia, withdrawal, and missed work. Evaluate a depressive disorder and suicide risk rather than increasing antiseizure medication or postponing mental health care until seizures recur.
Common pitfall: Functional seizures are classified within Epilepsy and episodic disorders in the ABPN outline. Their presence does not establish a separate depressive or anxiety disorder; assess those comorbidities directly.
ABPN Epilepsy Certification Content Specifications — December 2025 · AAN — Management of Functional Seizures: Clinician Summary
60.When is antiseizure medication unnecessary for functional seizures?
Antiseizure medication does not treat functional seizures themselves. When a careful assessment establishes no coexisting epilepsy or other indication, the AAN guideline supports a supervised taper and appropriate psychological treatment. Characterize all event types before changing therapy because functional and epileptic seizures can coexist. Explain that medication withdrawal follows diagnostic clarification and accompanies active treatment and continued care.
Apply it
Habitual functional events are documented and no independent indication remains for the antiseizure medication. Agree on a supervised taper, psychological treatment goals, and follow-up responsibilities.
Common pitfall: Continuing medication solely for functional events adds exposure without treating their mechanism. Abrupt withdrawal before checking for coexisting epilepsy or another indication creates a separate risk.
Interpersonal and communication skills1-3%
56.How should a functional seizure diagnosis be explained?
Explain the positive diagnostic reasoning, name functional seizures clearly, and state that the events are real and involuntary. Discuss how the findings distinguish the recorded events from epileptic seizures, while acknowledging any remaining uncertainty about other event types. The AAN guideline emphasizes respectful communication and shared decision-making. Invite the patient to describe their understanding and concerns, then connect the explanation to a treatment plan rather than leaving the discussion at a statement that the EEG was normal.
Apply it
After a habitual event is characterized, tell the patient what the observations support, explain the functional mechanism in accessible language, and ask them to describe the plan in their own words before arranging follow-up care.
Common pitfall: Saying only that there is nothing wrong, or that the EEG proves fabrication, undermines diagnostic understanding and confuses an involuntary functional disorder with deliberate symptom production.
Professionalism1-2%
57.What does respectful professional care require for functional seizures?
Professional care requires dignity, avoidance of stigmatizing language, and an honest account of what the evidence establishes. A functional diagnosis does not establish malingering, invalidate suffering, or justify abandonment. The AAN guideline emphasizes respect and continuity, including assessment for coexisting epilepsy and psychiatric conditions when relevant. Obtain informed participation in the management plan and communicate neutrally with other clinicians so that the diagnostic label does not become a reason to discount new symptoms without evaluation.
Apply it
A handoff describes a patient with functional seizures as attention seeking and recommends no further contact. Replace the stigmatizing characterization with the established diagnosis, relevant findings, current care plan, and reasons for reassessment if symptoms change.
Common pitfall: Treating a functional diagnosis as proof of deception violates dignity and can distort future clinical judgment, especially when a patient develops a new or coexisting medical disorder.
Practice-based learning and improvement1-2%
58.What did the childhood absence trial's freedom-from-treatment-failure endpoint measure?
The randomized trial assessed freedom from treatment failure at week 16, or week 20 after one permitted additional dose escalation. Failure included persistent clinical or electrographic absences at that assessment, a generalized tonic-clonic seizure at any time, specified systemic toxicity, dose-limiting toxicity despite one dose reduction, or parent- or physician-initiated withdrawal. Toxicity criteria included platelets below 50,000/mm³, aminotransferases at least 10 times the upper normal limit, and a BMI increase of at least 3.0 kg/m². Freedom-from-failure rates were ethosuximide 53%, valproic acid 58%, and lamotrigine 29%. Attentional dysfunction was a secondary outcome, occurring more often with valproic acid than ethosuximide: 49% versus 33%.
Apply it
A seizure-free child withdrawn because of qualifying toxicity still represents treatment failure. Both ethosuximide and valproic acid outperformed lamotrigine; their observed difference did not establish valproic acid superiority.
Common pitfall: These percentages combine effectiveness and tolerability in newly diagnosed childhood absence epilepsy. They do not measure lifelong cure or establish treatment rankings across all generalized epilepsies.
Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
Systems-based practice1-2%
59.How should driving advice account for jurisdiction and event risk?
Driving advice must consider the person's episodes, potential loss of control, applicable regional regulations, and any reporting obligations. A diagnosis alone does not supply a universal restriction interval, and functional seizures may still create driving risk. The AAN functional seizure guidance supports individualized advice consistent with regional rules. Document the counseling and help the patient identify feasible transport alternatives, because a restriction affects access to work and care even when it is clinically and legally necessary.
Apply it
A patient with functional events involving unresponsiveness asks whether the absence of epilepsy automatically permits driving. Review the actual impairment and applicable local requirements, document the advice, and discuss transport support for appointments and employment.
Common pitfall: Applying one jurisdiction's seizure-free interval everywhere, or assuming functional events cannot affect driving safety, substitutes a diagnosis-based shortcut for individualized risk assessment and applicable legal requirements.
AAN — Management of Functional Seizures: Clinician Summary · ABPN Epilepsy Certification Content Specifications — December 2025
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Give EEG interpretation and treatment decisions the largest share of study time, consistent with their respective 31–39% competency ranges.
- Classify events from onset, consciousness, and electroclinical evidence before assigning a syndrome or choosing medication coverage.
- Practise EEG polarity, background assessment, artifact discrimination, photic-stimulation safety, and ACNS frequency, duration, and seizure-burden calculations.
- Compare focal and generalized maintenance strategies, pediatric syndrome treatments, interaction-specific titration, and reproductive risks.
- Rehearse complete emergency sequences with doses, loading limits, response assessment, and escalation to anesthetic treatment with continuous EEG.
- Recognize drug resistance promptly, then use localization, concordance, and functional risk to explain procedural choices.
- Practise decisions involving vascular disease, empirical encephalitis treatment, tumor-related medication interactions, cognitive change, depression, and anxiety, then extend preparation through the full official outline.
A practical preparation plan
1. Map the full outline
Build a preparation grid from both official dimensions. Assign each topic a disorder category and a competency so that strong epilepsy knowledge does not hide gaps in diagnostic methods, professional practice, or less common etiologies.
2. Reconstruct events before naming them
For each case, write the earliest symptom, observed behavior, responsiveness, duration, recovery, and relevant triggers. Decide what is established and what remains uncertain before assigning seizure class or syndrome.
3. Read recordings with a fixed reasoning sequence
Assess recording quality, behavioral state, background, artifacts, spatial distribution, temporal evolution, and clinical correlation. Calculate seizure burden explicitly and compare the result with the correct ACNS definition.
4. Make treatment decisions explicit
State the seizure types requiring coverage, the evidence supporting the choice, the interaction or adverse effect most likely to change the plan, and the finding that would trigger escalation or referral. For emergencies, calculate the dose and maximum, specify the route, and state what follows treatment failure.
5. Use errors to select the next study task
Complete the independent drills, explain why every alternative is weaker, and classify each error as missing knowledge, misread evidence, or an incorrect decision threshold. Use the cards for spaced recall of the underlying distinction.
6. Rehearse patient explanations
Practise concise explanations of SUDEP, functional seizures, pregnancy decisions, and surgical evaluation. Connect uncertainty to a concrete management plan and check the patient's understanding.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- ABPN — Epilepsy: Initial Certification
- ABPN Epilepsy Certification Content Specifications — December 2025
- Instructions for the Subspecialty Certification Examination in Epilepsy
- ILAE — Updated Classification of Epileptic Seizures (2025)
- ILAE Official Report — A Practical Clinical Definition of Epilepsy
- GeneReviews — Glucose Transporter Type 1 Deficiency Syndrome
- ILAE EpilepsyDiagnosis.org — Juvenile Myoclonic Epilepsy: Overview
- ILAE EpilepsyDiagnosis.org — Juvenile Myoclonic Epilepsy: EEG
- ILAE EpilepsyDiagnosis.org — Epilepsy Imitators
- ACNS Guideline 7 — Guidelines for EEG Reporting
- Routine and Sleep EEG: Minimum Recording Standards of the IFCN and ILAE
- ACNS Standardized Critical Care EEG Terminology — 2021 Version
- ILAE EpilepsyDiagnosis.org — Hippocampal Sclerosis: Imaging
- AAN Clinician Summary — Use of fMRI in Presurgical Epilepsy Evaluation
- Faciobrachial Dystonic Seizures Precede LGI1 Antibody Limbic Encephalitis
- Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
- ILAE Surgical Therapies Commission — Timing of Referral for Epilepsy Surgery (2022)
- AES — Guideline for Treatment of Prolonged Seizures in Children and Adults
- AAN, AES, and SMFM — Guideline Issued for People with Epilepsy Who May Become Pregnant
- DailyMed — Lamotrigine Prescribing Information
- FDA Product Classification — Implanted Brain Stimulator for Epilepsy
- FDA-Hosted NeuroPace RNS System Patient Manual — Original Approval-Era Document
- AAN/AES Clinician Summary — SUDEP Incidence Rates and Risk Factors
- AAN — Management of Functional Seizures: Clinician Summary
- ILAE EpilepsyDiagnosis.org — Lennox-Gastaut Syndrome: EEG
- ILAE EpilepsyDiagnosis.org — Infantile Epileptic Spasms Syndrome: EEG
- DailyMed — Ethosuximide Oral Solution Prescribing Information
- updated-classification-of-epileptic-seizures-2025.pdf
- epi4.12414.pdf
- Routine-and-sleep-EEG-Minimum-recording-standards-of-the-internationa-federation-of-clinical-neurophysiology-and-the-international-league-against-epilepsy.pdf
- LENNOX-GASTAUT SYNDROME (LGS)
- International-MOGAD-Panel-Proposed-Criteria.pdf
- DownloadAsset.aspx
- Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial - PMC
- cse-treatment-chart-final_rerelease.pdf
- 989
- Epileptic_Disorders_2025_Schuele.pdf
- EEGGuideline3Montage_final20160323revclean_v1.pdf
- These highlights do not include all the information needed to use VALPROATE SODIUM INJECTION safely and effectively. See full prescribing information for VALPROATE SODIUM INJECTION. VALPROATE SODIUM injection, for intravenous injectionInitial U.S. Approval: 1996
- DailyMed - FOSPHENYTOIN SODIUM injection, solution
- P960009S219D.pdf
- The VNS Therapy Magnet - VNS Therapy Epilepsy | LivaNova UK
- IIS 10.0 Detailed Error - 999.0 - AW Special Error
- Auvin-etal_2024_Refining-management-strategies-for-Lennox-Gastaut-syndrome-Updated-algorithm.pdf
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.